Efficacy of Sertraline in Patients With Major Depressive Disorder Naive to Selective Serotonin Reuptake Inhibitors-Reference-Cited by-同舟云学术

Efficacy of Sertraline in Patients With Major Depressive Disorder Naive to Selective Serotonin Reuptake Inhibitors

Published:2018-10 Issue:5 Volume:38 Page:454-459
ISSN:1533-712X
Container-title:Journal of Clinical Psychopharmacology
language:en
Short-container-title:J Clin Psychopharmacol

Author:

Valle-Cabrera Roselin,Mendoza-Rodríguez Yudexi,Robaina-García Maytee,Ballesteros Javier,Cordero-Jiménez Juan Rafael,Espinosa-Rodríguez Nadia B.,Sotolongo-Garcia Yenia,Lauria-Horner Bianca

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Psychiatry and Mental health

Reference16 articles.

1. Cross-national epidemiology of DSM-IV major depressive episode;BMC Med,2011

2. Burden of depressive disorders by country, sex, age, and year: findings from the global burden of disease study 2010;PLoS Med,2013

3. Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2008 British Association for Psychopharmacology guidelines;J Psychopharmacol,2015

4. Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis;Lancet,2009

5. Sertraline versus other antidepressive agents for depression;Cochrane Database Syst Rev,2009

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Selection of the optimal dose of sertraline for depression: A dose-response meta-analysis of randomized controlled trials;Psychiatry Research;2023-09

2. Structural aspects, solid-state properties, and solubility performance of pharmaceutical sertraline-based organic salts;Journal of Molecular Structure;2023-02

3. Population Pharmacokinetic Modeling to Inform Sertraline Dosing Optimization in Patients with Depression;Pharmacology;2023

4. Risks of Digestive System Side-Effects of Selective Serotonin Reuptake Inhibitors in Patients with Depression: A Network Meta-Analysis;Therapeutics and Clinical Risk Management;2022-08

5. Concomitant medications, functional foods, and supplements: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022;Obesity Pillars;2022-06